Skip to main content

Teleflex Value Stock - Dividend - Research Selection

Teleflex

ISIN: US8793691069, WKN: 855853

Market price date: 26.01.2022
Market price: 298,74 USD


Teleflex Fundamental data and company key figures of the share

Annual reports in USD
Key figures 19-04-2021
Cash flow
Net operating cash flow 437.143.000
Capital Expenditures -90.694.000
Free cash flow 346.448.992
Balance sheet
Total Equity 3.336.460.000
Liabilities & Shareholders equity 7.152.560.000
Income statement
Net income 335.324.000
Eps (diluted) 7,090
Diluted shares outstanding 46.680.000
Net sales/revenue 2.537.160.000

Fundamental ratios calculated on: 26-01-2022

Ratios
Key figures 26-01-2022
Cash flow
P/C 32,51
   
P/FC 40,25
Balance sheet
ROI4,69
ROE46,65
Income statement
P/E42,14
Div. Yield0,45%
P/B4,26
P/S5,50


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolTFX
Market Capitalization14.210.325.504,00 USD
CountryUnited States
Indices,MSCI World Index
SectorsHealth Care Equipment
Raw Data SourceUS GAAP in Millionen USD
Stock Split1997-06-17,2.000000/1.000000; 1991-06-17,3.000000/2.000000; 1986-06-17,2.000000/1.000000; 1981-09-16,3.000000/2.000000; 1980-12-16,2.000000/1.000000; 1978-06-16,2.000000/1.000000
Internetwww.teleflex.com


Description of the company

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.teleflex.com


NEWS


Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition

2022-01-24
Netflix tumbled for a second day on Monday after the company's weaker-than-expected subscriber forecast.

Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more

2022-01-24
These are the stocks posting the largest moves in midday trading.

RBC upgrades Comcast to outperform on subscriber growth

2022-01-24
CNBC's Julia Boorstin reports on legal media companies which are ticking higher despite a broader sell-off. (Comcast is CNBC's parent company.)

What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020

2022-01-24
U.S. stock futures indicated more losses to start the new week following the Nasdaq's and the S&P 500's worst weeks since March 2020.

Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more

2022-01-24
The stocks making the biggest moves in premarket trading include Kohl's, Snap, Peloton, and more.

Earnings playbook: A complete guide to this week's reports, including the first of tech

2022-01-23
Microsoft, Tesla and Apple will release quarterly results, alongside a handful of other tech firms. McDonald's and Boeing will also offer updates.

Teleflex Inc. stock underperforms Friday when compared to competitors

2022-01-21
Shares of Teleflex Inc. shed 0.50% to $323.20 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...

Markets are expected to remain on edge as the Fed meets in the week ahead

2022-01-21
The Federal Reserve's meeting trumps everything else for markets in the week ahead, as investors await any new clues on its plans to raise interest rates.

Netflix quietly admits streaming competition is eating into growth

2022-01-20
Netflix added a line in its quarterly shareholder letter acknowledging streaming competition is affecting its "marginal growth."

Teleflex Inc. stock underperforms Thursday when compared to competitors

2022-01-20
Shares of Teleflex Inc. shed 2.41% to $324.83 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...